Medscape
TOPLINE: Adalimumab combined with corticosteroids was more advantageous than cyclosporine combined with corticosteroids in preventing uveitis relapse while maintaining a favorable safety profile in patients with severe Behçet disease. In contrast, interferon alfa-2a is not superior to cyclosporine in terms of efficacy. METHODOLOGY: Researchers compared the efficacy and safety of three immunomodulatory agents (cyclosporine…
Read More
Adalimumab Tops Cyclosporine in Preventing Uveitis Relapse
TOPLINE: Adalimumab combined with corticosteroids was more advantageous than cyclosporine combined with corticosteroids in preventing uveitis relapse while maintaining a favorable safety profile in patients with severe Behçet disease. In contrast, interferon alfa-2a is not superior to cyclosporine in terms of efficacy. METHODOLOGY: Researchers compared the efficacy and safety of three immunomodulatory agents (cyclosporine…